March 18, 2016 | Decision-making, Pegasus
To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy area. That model is called Healthscapes, the product of an extensive academic literature review, focus groups and a questionnaire among 10,000 people.
When used in conjunction with our Pegasus Panel, a bespoke database of industry experts, healthcare professionals and media consultants, Healthscapes improves the depth of exploration and the quality of insight generated and forms the backbone of our planning approach.
Find out more at info@thisispegasus.co.uk or by calling +44 (0) 1273 712 000.
This content was provided by Inizio
Latest Content from Inizio
Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
As it’s our 20th year anniversary, we invited our employees to play 20 questions – this month “What’s the biggest challenge you’ve overcome at Research Partnership?”Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/
A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline…
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
A few key considerations for conducting healthcare market research in the Gulf
Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a…
Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST
Published in eyeforpharma February 2017 by Marc Yates
Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research…
Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and…
